BioForum 2010 Key Note SPEAKER:
Valeria Povolotsky, Director at Global Business Development, Hoffmann-La Roche Inc.

Director, Global Business Development, Roche Partnering, Roche, Nutley, NJ, US.

Dr Povolotsky is an expert in Biotech/Pharma Licensing & Investment with over 20 years experience in R&D and Global Business Development. With a strong background in science, (Master in Biochemistry and PhD in Pharmacology), Dr Povolotsky spent over 12 years in the drug development from preclinical research, clinical and regulatory, then moving to Business Development for the last 10 years, focusing on the Venture investments (Magellan Summit), Scientific Intelligence (Daiichi-Sankyo), and Partnering (Roche). Dr Povolotsky is currently responsible for finding innovations and potential opportunities for collaboration in the Emerging Markets.

Roche: New Ways of Creative Partnership

Starting from March 1st 2010, Roche Partnering has launched new Partnering program (Helios), which is entirely dedicated to the the Emerging Markets, and which has strong focus on the Eastern Europe. The major purpose of this program is to find innovations and to build creative partnerships to develop new drugs, and to make difference in patient’s lives.    More information...